Sprint Bioscience AB (publ) (FRA:5JA1)
Germany · Delayed Price · Currency is EUR 0.1100
-0.0020 (-1.79%)
At close: Dec 19, 2025
Sprint Bioscience AB Market Cap
Sprint Bioscience AB has a market cap or net worth of €13.88 million as of December 22, 2025. Its market cap has increased by 32.34% in one year.
Market Cap
13.88M
Enterprise Value
12.88M
Revenue
4.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.11
Market Cap Chart
Since November 7, 2014, Sprint Bioscience AB's market cap has increased from 6.77M to 13.88M, an increase of 105.02%. That is a compound annual growth rate of 6.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 13.88M | 44.03% |
| Dec 30, 2024 | 9.64M | -11.30% |
| Dec 29, 2023 | 10.87M | 449.41% |
| Dec 30, 2022 | 1.98M | -89.40% |
| Dec 30, 2021 | 18.65M | 15.29% |
| Dec 30, 2020 | 16.18M | 19.26% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.93B |
| Siemens Aktiengesellschaft | 183.57B |
| Allianz SE | 146.73B |
| Deutsche Telekom AG | 130.04B |
| Siemens Energy AG | 102.30B |
| Rheinmetall AG | 71.12B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 70.51B |
| Deutsche Bank Aktiengesellschaft | 62.30B |